|
1
|
Brownlee M: Biochemistry and molecular
cell biology of diabetic complications. Nature. 414:813–820. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ren J and Davidoff AJ: Diabetes rapidly
induces contractile dysfunctions in isolated ventricular myocytes.
Am J Physiol. 272:H148–H158. 1997.PubMed/NCBI
|
|
3
|
Xu W, Wu W, Chen J, Guo R, Lin J, Liao X
and Feng J: Exogenous hydrogen sulfide protects H9c2 cardiac cells
against high glucose-induced injury by inhibiting the activities of
the p38 MAPK and ERK1/2 pathways. Int J Mol Med. 32:917–925.
2013.PubMed/NCBI
|
|
4
|
Soetikno V, Sari FR, Sukumaran V,
Lakshmanan AP, Mito S, Harima M, Thandavarayan RA, Suzuki K, Nagata
M, Takagi R, et al: Curcumin prevents diabetic cardiomyopathy in
streptozotocin-induced diabetic rats: possible involvement of
PKC-MAPK signaling pathway. Eur J Pharm Sci. 47:604–614. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Peake BF, Nicholson CK, Lambert JP, Hood
RL, Amin H, Amin S and Calvert JW: Hydrogen sulfide preconditions
the db/db diabetic mouse heart against ischemia-reperfusion injury
by activating Nrf2 signaling in an Erk-dependent manner. Am J
Physiol Heart Circ Physiol. 304:H1215–H1224. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen J, Mo H, Guo R, You Q, Huang R and Wu
K: Inhibition of the leptin-induced activation of the p38 MAPK
pathway contributes to the protective effects of naringin against
high glucose-induced injury in H9c2 cardiac cells. Int J Mol Med.
33:605–612. 2014.PubMed/NCBI
|
|
7
|
Huang H and Wu K, You Q, Huang R, Li S and
Wu K: Naringin inhibits high glucose-induced cardiomyocyte
apoptosis by attenuating mitochondrial dysfunction and modulating
the activation of the p38 signaling pathway. Int J Mol Med.
32:396–402. 2013.PubMed/NCBI
|
|
8
|
Cai L, Li W, Wang G, Guo L, Jiang Y and
Kang YJ: Hyperglycemia-induced apoptosis in mouse myocardium:
mitochondrial cytochrome C-mediated caspase-3 activation pathway.
Diabetes. 51:1938–1948. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen J, Guo R, Yan H, Tian L, You Q, Li S,
Huang R and Wu K: Naringin inhibits ROS-activated MAPK pathway in
high glucose-induced injuries in H9c2 cardiac cells. Basic Clin
Pharmacol Toxicol. 114:293–304. 2014. View Article : Google Scholar
|
|
10
|
Fiordaliso F, Leri A, Cesselli D, Limana
F, Safai B, Nadal-Ginard B, Anversa P and Kajstura J: Hyperglycemia
activates p53 and p53-regulated genes leading to myocyte cell
death. Diabetes. 50:2363–2375. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fei L, Yong-Jun H, Zhang-Min M, Bing X,
Shuang W, Qian-qian S and Jun L: Rosiglitazone attenuates memory
impairment in aged rat with diabetes by inhibiting NF-kappa B
signal pathway activation. Exp Clin Endocrinol Diabetes.
123:536–542. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Thandavarayan RA, Giridharan VV, Sari FR,
Arumugam S, Veeraveedu PT, Pandian GN, Palaniyandi SS, Ma M, Suzuki
K, Gurusamy N, et al: Depletion of 14-3-3 protein exacerbates
cardiac oxidative stress, inflammation and remodeling process via
modulation of MAPK/NF-κB signaling pathways after
streptozotocin-induced diabetes mellitus. Cell Physiol Biochem.
28:911–922. 2011. View Article : Google Scholar
|
|
13
|
Xu W, Chen J, Lin J, Liu D, Mo L, Pan W,
Feng J, Wu W and Zheng D: Exogenous H S protects H9c2 cardiac cells
against high glucose-induced injury 2 and inflammation by
inhibiting the activation of the NF-κB and IL-1β pathways. Int J
Mol Med. 35:177–186. 2015.
|
|
14
|
Kung G, Konstantinidis K and Kitsis RN:
Programmed necrosis, not apoptosis, in the heart. Circ Res.
108:1017–1036. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Declercq W, Vanden Berghe T and
Vandenabeele P: RIP kinases at the crossroads of cell death and
survival. Cell. 138:229–232. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang DW, Shao J, Lin J, Zhang N, Lu BJ,
Lin SC, Dong MQ and Han J: RIP3, an energy metabolism regulator
that switches TNF-induced cell death from apoptosis to necrosis.
Science. 325:332–336. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
He S, Wang L, Miao L, Wang T, Du F, Zhao L
and Wang X: Receptor interacting protein kinase-3 determines
cellular necrotic response to TNF-alpha. Cell. 137:1100–1111. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cho YS, Challa S, Moquin D, Genga R, Ray
TD, Guildford M and Chan FK: Phosphorylation-driven assembly of the
RIP1-RIP3 complex regulates programmed necrosis and virus-induced
inflammation. Cell. 137:1112–1123. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Linkermann A, Hackl MJ, Kunzendorf U,
Walczak H, Krautwald S and Jevnikar AM: Necroptosis in immunity and
ischemia-reperfusion injury. Am J Transplant. 13:2797–2804. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dmitriev YV, Minasian SM, Demchenko EA and
Galagudza MM: Study of cardioprotective effects of necroptosis
inhibitors on isolated rat heart subjected to global
ischemia-reperfusion. Bull Exp Biol Med. 155:245–248. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Koshinuma S, Miyamae M, Kaneda K, Kotani J
and Figueredo VM: Combination of necroptosis and apoptosis
inhibition enhances cardioprotection against myocardial
ischemia-reperfusion injury. J Anesth. 28:235–241. 2014. View Article : Google Scholar
|
|
22
|
Liu YS, Huang ZW, Wang L, Liu XX, Wang YM,
Zhang Y and Zhang M: Sitagliptin alleviated myocardial remodeling
of the left ventricle and improved cardiac diastolic dysfunction in
diabetic rats. J Pharmacol Sci. 127:260–274. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Oerlemans MI, Liu J, Arslan F, den Ouden
K, van Middelaar BJ, Doevendans PA and Sluijter JP: Inhibition of
RIP1-dependent necrosis prevents adverse cardiac remodeling after
myocardial ischemia-reperfusion in vivo. Basic Res Cardiol.
107:2702012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lim SY, Davidson SM, Mocanu MM, Yellon DM
and Smith CC: The cardioprotective effect of necrostatin requires
the cyclophilin-D component of the mitochondrial permeability
transition pore. Cardiovasc Drugs Ther. 21:467–469. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Smith CC, Davidson SM, Lim SY, Simpkin JC,
Hothersall JS and Yellon DM: Necrostatin: a potentially novel
cardioprotective agent? Cardiovasc Drugs Ther. 21:227–233. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Luedde M, Lutz M, Carter N, Sosna J,
Jacoby C, Vucur M, Gautheron J, Roderburg C, Borg N, Reisinger F,
et al: RIP3, a kinase promoting necroptotic cell death, mediates
adverse remodelling after myocardial infarction. Cardiovasc Res.
103:206–216. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Meng L, Jin W and Wang X: RIP3-mediated
necrotic cell death accelerates systematic inflammation and
mortality. Proc Natl Acad Sci USA. 112:11007–11012. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Han D, Ybanez MD, Ahmadi S, Yeh K and
Kaplowitz N: Redox regulation of tumor necrosis factor signaling.
Antioxid Redox Signal. 11:2245–2263. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Morgan MJ and Liu ZG: Reactive oxygen
species in TNFalpha-induced signaling and cell death. Mol Cells.
30:1–12. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fortes GB, Alves LS, de Oliveira R, Dutra
FF, Rodrigues D, Fernandez PL, Souto-Padron T, De Rosa MJ, Kelliher
M, Golenbock D, et al: Heme induces programmed necrosis on
macrophages through autocrine TNF and ROS production. Blood.
119:2368–2375. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ye YC, Wang HJ, Yu L, Tashiro S, Onodera S
and Ikejima T: RIP1-mediated mitochondrial dysfunction and ROS
production contributed to tumor necrosis factor alpha-induced L929
cell necroptosis and autophagy. Int Immunopharmacol. 14:674–682.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yu X, Deng Q, Li W, Xiao L, Luo X, Liu X,
Yang L, Peng S, Ding Z, Feng T, et al: Neoalbaconol induces cell
death through necroptosis by regulating RIPK-dependent autocrine
TNFα and ROS production. Oncotarget. 6:1995–2008. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kikuchi M, Kuroki S, Kayama M, Sakaguchi
S, Lee KK and Yonehara S: Protease activity of procaspase-8 is
essential for cell survival by inhibiting both apoptotic and
nonapoptotic cell death dependent on receptor-interacting protein
kinase 1 (RIP1) and RIP3. J Biol Chem. 287:41165–41173. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Schenk B and Fulda S: Reactive oxygen
species regulate Smac mimetic/TNFα-induced necroptotic signaling
and cell death. Oncogene. 34:5796–5806. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nunes T, Bernardazzi C and de Souza HS:
Cell death and inflammatory bowel diseases: apoptosis, necrosis,
and autophagy in the intestinal epithelium. BioMed Res Int.
2014:2184932014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fenton K: The effect of cell death in the
initiation of lupus nephritis. Clin Exp Immunol. 179:11–16. 2015.
View Article : Google Scholar
|
|
37
|
Su Z, Yang Z, Xu Y, Chen Y and Yu Q:
Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol
Cancer. 14:482015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fang ZY, Prins JB and Marwick TH: Diabetic
cardiomyopathy: evidence, mechanisms, and therapeutic implications.
Endocr Rev. 25:543–567. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shimomura H, Terasaki F, Hayashi T,
Kitaura Y, Isomura T and Suma H: Autophagic degeneration as a
possible mechanism of myocardial cell death in dilated
cardiomyopathy. Jpn Circ J. 65:965–968. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Vanlangenakker N, Vanden Berghe T and
Vandenabeele P: Many stimuli pull the necrotic trigger, an
overview. Cell Death Differ. 19:75–86. 2012. View Article : Google Scholar :
|
|
41
|
Boudina S, Sena S, Theobald H, Sheng X,
Wright JJ, Hu XX, Aziz S, Johnson JI, Bugger H, Zaha VG, et al:
Mitochondrial energetics in the heart in obesity-related diabetes:
direct evidence for increased uncoupled respiration and activation
of uncoupling proteins. Diabetes. 56:2457–2466. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Agrawal NK and Kant S: Targeting
inflammation in diabetes: newer therapeutic options. World J
Diabetes. 5:697–710. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Fang Q, Wang J, Wang L, Zhang Y, Yin H, Li
Y, Tong C, Liang G and Zheng C: Attenuation of inflammatory
response by a novel chalcone protects kidney and heart from
hyperglycemia-induced injuries in type 1 diabetic mice. Toxicol
Appl Pharmacol. 288:179–191. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yu X, Deng Q, Bode AM, Dong Z and Cao Y:
The role of necroptosis, an alternative form of cell death, in
cancer therapy. Expert Rev Anticancer Ther. 13:883–893. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yang Y, Jiang G, Zhang P and Fan J:
Programmed cell death and its role in inflammation. Mil Med Res.
2:122015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Liu ZY, Wu B, Guo YS, Zhou YH, Fu ZG, Xu
BQ, Li JH, Jing L, Jiang JL, Tang J, et al: Necrostatin-1 reduces
intestinal inflammation and colitis-associated tumorigenesis in
mice. Am J Cancer Res. 5:3174–3185. 2015.PubMed/NCBI
|
